Cargando…

Side effects of ruxolitinib in patients with SARS-CoV-2 infection: Two case reports

Detalles Bibliográficos
Autores principales:	Gaspari, Valeria, Zengarini, Corrado, Greco, Sonia, Vangeli, Valeria, Mastroianni, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. and International Society of Chemotherapy. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243754/ https://www.ncbi.nlm.nih.gov/pubmed/32450201 http://dx.doi.org/10.1016/j.ijantimicag.2020.106023

Ejemplares similares

Turicella otitidis central venous-related bacteremia during pediatric acute lymphoblastic leukemia
por: Mastroianni, Antonio, et al.
Publicado: (2023)

Humoral and cellular responses after third dose of SARS-CoV-2 vaccine in myeloproliferative neoplasms patients on ruxolitinib therapy
por: Atanasio, A., et al.
Publicado: (2023)

Low-dose ruxolitinib plus steroid in severe SARS-CoV-2 pneumonia
por: D’Alessio, A., et al.
Publicado: (2020)

SARS-CoV-2 infection in a pediatrics STAT1 GOF patient under Ruxolitinib therapy-a matter of balance?
por: Guisado Hernández, Paloma, et al.
Publicado: (2021)

IFN-α levels in ruxolitinib-treatead Aicardi-Goutières patient during SARS-CoV-2 infection: A case report
por: Badolato, Raffaele, et al.
Publicado: (2021)

Does Tigecycline Have a Place in Therapy for Rickettsial Infection of the Central Nervous System?
por: Mastroianni, Antonio, et al.
Publicado: (2022)

Convalescent plasma transfusion for pregnant patients with COVID-19
por: Mastroianni, Antonio, et al.
Publicado: (2021)

Occult Cytomegalovirus Cholangitis and Pancreatic Adenocarcinoma: A Case Report
por: Mastroianni, Antonio, et al.
Publicado: (2023)

Ruxolitinib therapy and telomere length in myelofibrosis
por: Caocci, G, et al.
Publicado: (2016)

Sars-CoV-2 and black population: ACE2 as shield or blade?
por: Vinciguerra, Mattia, et al.
Publicado: (2020)

Intrathecal tigecycline is a safe and effective treatment for central nervous system infections
por: Mastroianni, Antonio, et al.
Publicado: (2023)

Early use of canakinumab to prevent mechanical ventilation in select COVID-19 patients: A retrospective, observational analysis
por: Mastroianni, Antonio, et al.
Publicado: (2021)

Altitude does not protect against SARS‐CoV‐2 infections and mortality due to COVID‐19
por: Cardenas, Laura, et al.
Publicado: (2021)

SARS-CoV-2 and dentistry
por: Ortega, Karem L., et al.
Publicado: (2020)

SARS-CoV-2 infection in patients with chronic kidney disease on haemodialysis. Evolution of SARS-CoV-2 CRP()
por: Zúñiga, José, et al.
Publicado: (2021)

New-Generation Quantitative Immunoassays for SARS-CoV-2 Antibody Detection: Need for Harmonization
por: Villalta, Danilo, et al.
Publicado: (2022)

The Role of the SARS-CoV-2 Pandemic on Suicide Rates: Preliminary Study in a Sample of the Greek Population
por: Karakasi, Maria-Valeria, et al.
Publicado: (2021)

Two SARS-CoV-2 serology assays detect antibodies in the sera of individuals diagnosed with SARS-CoV-2 Omicron variant
por: Conklin, Justin, et al.
Publicado: (2022)

Immune response in SARS-CoV-2
por: Aguilar-Shea, Antonio Luis, et al.
Publicado: (2020)

Is SARS-CoV-2 an oncogenic virus?
por: Gómez-Carballa, Alberto, et al.
Publicado: (2022)

The nature and severity of SARS-CoV-2 vaccine side effects in athletes are highly dependent on study design
por: Finsterer, Josef, et al.
Publicado: (2023)

Improved gut microbiota features after the resolution of SARS‑CoV‑2 infection
por: De Maio, Flavio, et al.
Publicado: (2021)

Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)

SARS-CoV-2 in cardiomyocytes
por: Finsterer, Josef
Publicado: (2021)

Pharmacotherapeutics of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

Comment on “Comparative Population Pharmacokinetics of Darunavir in SARS-CoV-2 Patients vs. HIV Patients: The Role of Interleukin-6”
por: Cattaneo, Dario, et al.
Publicado: (2021)

Efficacy of ruxolitinib on hepatomegaly in patients with myelofibrosis
por: Verstovsek, S, et al.
Publicado: (2016)

SARS-CoV-2 and Legionella Co-Infection
por: Gauvin, Caitlin A., et al.
Publicado: (2023)

A stark difference in the profiles of defective viral transcripts between SARS-CoV-2 and SARS-CoV
por: Xie, Dongying, et al.
Publicado: (2021)

SARS CoV-2 genetic jump to a new SARS CoV-3 pandemic: Let’s be prepared
por: Kelleni, Mina T.
Publicado: (2023)

SARS-CoV-2 infection in aplastic anemia
por: Avenoso, Daniele, et al.
Publicado: (2021)

SARS‐CoV‐2 immunogenicity at the crossroads
por: Karamloo, Fariba, et al.
Publicado: (2020)

Transmission routes of SARS-CoV-2
por: Patel, Jay
Publicado: (2020)

SARS-CoV-2 and EBV coinfection()
por: García-Martínez, Francisco Javier, et al.
Publicado: (2020)

Peptide Targets to SARS-CoV-2
por: Mandal, Santi M.
Publicado: (2020)

On aerosol transmission of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2021)

Living evidence for SARS-CoV-2()
por: Santillan-Garcia, A.
Publicado: (2021)

Esophagitis and SARS-CoV-2 vaccine
por: Sriwijitalai, Won, et al.
Publicado: (2023)

Routes of transmission of SARS-CoV-2
por: Gupta, Harish, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lkad1rh7akapvaetac9l89f0ni